Antitumor Effects of Interferon-Alpha on Cell Growth and Metastasis in Human Nasopharyngeal Carcinoma

被引:31
作者
Liu, X. [1 ]
Lu, J. [1 ]
He, M. -L. [2 ,3 ]
Li, Z. [4 ]
Zhang, B. [5 ]
Zhou, L. -H. [6 ]
Li, Q. [1 ]
Li, G. [1 ]
Wang, L. [1 ]
Tian, W. -D. [1 ]
Peng, Y. [7 ]
Li, X. -P. [1 ]
机构
[1] So Med Univ, Nanfang Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou 510515, Guangdong, Peoples R China
[2] Chinese Univ Hong Kong, Sch Publ Hlth, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China
[4] Shaanxi Normal Univ, Coll Life Sci, Mol Microbiol Lab, Xian 710062, Peoples R China
[5] So Med Univ, Inst Genet Engn, Guangzhou 510515, Guangdong, Peoples R China
[6] 150 Cent Hosp PLA, Dept Otolaryngol Head & Neck Surg, Luoyang 471037, Peoples R China
[7] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510120, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell growth; cytokine; immunotherapy; interferon-alpha; 1b; metastasis; nasopharyngeal carcinoma; TUMOR-INFILTRATING LYMPHOCYTES; FACTOR RECEPTOR; I INTERFERON; IFN-ALPHA; T-CELLS; CANCER; EXPRESSION; SURVIVAL; PATHWAY; HEAD;
D O I
10.2174/156800912800673293
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Nasopharyngeal carcinoma (NPC) is a highly malignant and frequently metastasized tumor, and the prognosis is very poor when distant metastases occur. Recently, immunotherapy is becoming a promising therapeutic approach. Interferon-alpha (IFN-alpha) represents the cytokines exhibiting the longest record of use in clinical oncology. In this study, we examined the antitumor effects of IFN-alpha 1b on NPC. The results showed that recombinant human IFN-alpha 1b (hIFN-alpha 1b) suppressed cell growth, induced a G1-phase cell cycle arrest in vitro, increased the expression of p16 and pRb, and decreased the expression of CCND1 and CDK6. In vivo analyses showed that either recombinant adeno-associated virus (rAAV)-IFN-alpha 1b or hIFN-alpha 1b treatment inhibited tumor growth and metastasis, reduced intratumoral microvessel density, increased cell apoptosis and necrosis, and induced prolonged survival. Notably, rAAV-IFN-alpha 1b or hIFN-alpha 1b treatment led to significantly higher serum levels of IL-12 and GM-CSF in mice compared to respective controls. Our findings suggest that IFN-alpha 1b acts as a multifunctional antitumor agent in NPC, which may have important therapeutic implications.
引用
收藏
页码:561 / 570
页数:10
相关论文
共 50 条
[1]
Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors [J].
Airoldi, Irma ;
Ribatti, Domenico .
JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 90 (05) :875-882
[2]
T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer [J].
Albers, A. E. ;
Strauss, L. ;
Liao, T. ;
Hoffmann, T. K. ;
Kaufmann, A. M. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
[3]
Different interferons: pharmacology, pharmacokinetics, proposed mechanisms, safety and side effects [J].
Arnaud, P .
REVUE DE MEDECINE INTERNE, 2002, 23 :449S-458S
[4]
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column [J].
Auricchio, A ;
Hildinger, M ;
O'Connor, E ;
Gao, GP ;
Wilson, JM .
HUMAN GENE THERAPY, 2001, 12 (01) :71-76
[5]
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers [J].
Badoual, C ;
Hans, S ;
Rodriguez, J ;
Peyrard, S ;
Klein, C ;
Agueznay, NE ;
Mosseri, V ;
Laccourreye, O ;
Bruneval, P ;
Fridman, WH ;
Brasnu, DF ;
Tartour, E .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :465-472
[6]
The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[7]
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-α in head and neck cancer cells in vitro and in vivo [J].
Bruzzese, F ;
Di Gennaro, E ;
Avallone, A ;
Pepe, S ;
Arra, C ;
Caraglia, M ;
Tagliaferri, P ;
Budillon, A .
CLINICAL CANCER RESEARCH, 2006, 12 (02) :617-625
[8]
EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-α-mediated apoptosis in epidermoid cancer cells [J].
Caraglia, M ;
Tagliaferri, P ;
Marra, M ;
Giuberti, G ;
Budillon, A ;
Di Gennaro, E ;
Pepe, S ;
Vitale, G ;
Improta, S ;
Tassone, P ;
Venuta, S ;
Bianco, AR ;
Abbruzzese, A .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (02) :218-229
[9]
Interferon-α induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor [J].
Caraglia, M ;
Abbruzzese, A ;
Leardi, A ;
Pepe, S ;
Budillon, A ;
Baldassare, G ;
Selleri, C ;
De Lorenzo, S ;
Fabbrocini, A ;
Giuberti, G ;
Vitale, G ;
Lupoli, G ;
Bianco, AR ;
Tagliaferri, P .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (08) :773-780
[10]
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay [J].
Carson, RT ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 227 (1-2) :41-52